Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Cell Genesys
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Histologically confirmed adenocarcinoma of the prostate
Metastatic prostate cancer deemed to be unresponsive or refractory to hormone therapy (after discontinuation of anti-androgen therapy)
Detectable metastases by bone scan, and/or CT scan, and/or MRI, and/or CXR
ECOG performance status 0-1
You may not be if
Transitional cell, small cell, neuroendocrine, or squamous cell prostate cancer
History of deep vein thrombosis or pulmonary embolus
Patients taking anticoagulants (such as coumadin or Heparin). The use of aspirin while on study is acceptable.
History of a bleeding disorder or recent clinically significant bleeding
Seropositive for HIV
History of Hepatitis B, Hepatitis C, or chronic liver disease
Prior gene therapy or immunotherapy
Prior chemotherapy for prostate cancer
Radiation therapy within 4 weeks of the first treatment.
History of myocardial infarction within 6 months of the first treatment
History of cerebrovascular accident
History of previous malignancy, except for the following: adequately treated basal cell or squamous cell skin cancer, superficial bladder cancer, adequately treated Stage I or II cancer currently in complete remission, or any other cancer that has been in complete remission for at least 5 years
Evidence of active prostatitis
Known hypersensitivity to docetaxel or to other drugs formulated with polysorbate 80
